Michael O'LearyNew drug improves survival in advanced ovarian cancerCANCER DIGEST – June 24, 2023 – Nearly half of women with advanced ovarian cancer that is resistant to standard chemotherapy survived...
Michael O'LearyKeytruda boosts survival in advanced cervical cancer as first line therapyCANCER DIGEST – May 27, 2023 – Women with persistent, recurrent or cervical cancer that has spread to other tissues had improved overall...
Michael O'LearyNew combination therapy shows promise for advanced ovarian cancerSaturday, February 19, 2022 CANCER DIGEST – Feb. 19, 2022 – Ovarian cancer patients whose tumors have recurred or resisted standard...